Visit us at RAPS Convergence 2022

Visit us at RAPS Convergence 2022

Visit us at RAPS Convergence 2022

RAPS Convergence 2022 returns in-person, bringing industry professionals and regulators together to co-create, problem-solve and discuss global and local challenges facing professionals in the regulatory life sciences community.

It will be thrilling to return to a face to face gathering of such prestigious individuals and companies in Phoenix from September 11-13. This is a great opportunity to take stock of the impact of the past few years and take the pulse of the wider life sciences industry.

The Amplexor Life Sciences team can be found at Booth 612. If you would like to schedule a meeting with us at RAPS Convergence 2022, please fill out this form. 

Get in touch with an expert

Connect with us today!

Visit us at DIA 2022 Global Annual Meeting

Visit us at DIA 2022 Global Annual Meeting

Visit us at DIA 2022 Global Annual Meeting

For the first time in several years, the DIA 2022 Global Annual Meeting returns in-person, bringing industry professionals, regulators, academics and patients together to co-create, problem-solve and discuss global and local challenges facing professionals in the life sciences community.

It will be thrilling to return to a face to face gathering of such prestigious individuals and companies in the great city of Chicago. This is a great opportunity to take stock of the impact of the past few years and take the pulse of the wider life sciences industry.

The Amplexor Life Sciences team can be found at Booth 2039. If you would like to schedule a meeting with us at DIA 2022, please fill out this form. 

Get in touch with an expert

Connect with us today!

Amplexor Life Sciences’ annual Be The Expert conference

Amplexor Life Sciences’ annual Be The Expert conference

Amplexor Life Sciences’ annual Be The Expert conference

Amplexor Life Sciences’ annual BE THE EXPERT conference brings together leading global subject matter experts to explore the latest trends in IDMP, RIM, Labelling and Quality.

We are happy to unveil the agenda for the upcoming Be The Expert conference, a virtual gathering of prominent life sciences industry professionals, including Kelly Hnat of K2 Consulting, Steve Gens of Gens & Associates, Iperion’s Remco Munnik and Tris Nockles from IRISS-Forum.

Be The Expert 2022 will be staged as a three-day virtual event, accessible online between June 7 and June 9, focusing on the key trends driving life sciences today. Sessions will examine a wide range of topics, from risk management in pharma to how cloud solutions can reduce volatility and IDMP’s impact on labelling and submission.

As one of several high-profile industry thought leaders, Steve Gens will provide insight into how companies are evolving and investing in the near and longer term in RIM solutions. This session will highlight key learnings from the 2022 Q2 Gens & Associates World Class RIM benchmark of 70 + companies, as well as the recent COVID-19 Regulatory Impact follow-up study, with an emphasis on advanced technology priorities, investments, and current performance levels.

The conference will also enable attendees to:

  • Keep updated on EU IDMP implementation and the Digital Application Dataset Integration (DADI) project
  • Maintain and improve compliance throughout the product lifecycle and evolving regulatory requirements
  • Improve operational efficiencies and information flows
  • Bridge current services with innovative technologies while reducing costs
  • Introduce innovations that can help drive business transformation and reinforce competitive positioning

At the same time, themed presentations will explore the most pressing issues facing life sciences professionals, including RIM/Analytics; RegOps/eSubmissions; Labelling/Artwork/ePI; Quality/Compliance; and Cloud technologies.

 

Register now for the most topical and insightful life sciences event on the calendar here.

We look forward to welcoming you to our first BE THE EXPERT virtual experience in June!

Get in touch with an expert

Connect with us today!

Announcing Amplexor Life Sciences Suite 7.0 for the data-driven age

Announcing Amplexor Life Sciences Suite 7.0 for the data-driven age

Major new platform release & redesigned ProductExpert™ and SubmissionExpert™ solutions provide full support for IDMP data models & processes, and a faster and more intuitive submission management and publishing experience for users

Amplexor Life Sciences has kicked off 2022 with a new generation of our core platform and solution suite optimised for the data-driven age. Following on the introduction of Life Sciences Analytics in version 6, we have now released the next major product release package – 7.0 – across our platform and solutions.

Fast, intuitive and compliant data & submission management

This major release represents a complete overhaul of our platform and solutions in the two major areas of data management and submission management, offering users both a more futureproof suite of capabilities and a more intuitive and responsive experience to support their everyday work.

Our master and product data management solution ProductExpert 7.0 has been redesigned according to the requirements of the EU IDMP implementation guidelines v2.1. This enables our customers to bring their product data in line with the upcoming DADI data submission mandate in the EU and prepare for fuller data-driven regulatory information management in due course – as IDMP and the fuller Target Operating Model become the default means of regulatory exchange. New repository-agnostic platform capabilities allow for efficient management and reuse of IDMP data elements without duplication of data.

Linked to this, our upgraded submission management and publishing solution SubmissionExpert 7.0 supports document-level content planning; complete separation of document and submission relevant metadata; as well as in-line lifecycle management and viewing. Combined with substantial improvements to performance and the introduction of incremental publishing earlier last year, this brings the submission manager’s user experience to a completely new level.

Improved traceability

Platform improvements in myProcess 7.0, meanwhile, include redesigned audit trail actions, updated middleware component compatibility, and the discontinuation of old technology dependencies – including end of support for Internet Explorer 11 in favour of the modern Chrome, Edge and Safari browsers which are already supported.

The new version has also greatly optimised the upgrade process, making platform refreshes as smooth and fast as possible – for on-premise deployments as well as those provisioned via the cloud.

These are just some of the highlights of our new, improved platform and solution suite. As ever, we’ll continue to improve our offerings based on your feedback, incorporating new compliance requirements and shaping the industry trends as these evolve throughout 2022.

To find out more, register for our product webinars or join our customer circles contact our representatives!

Amplexor and Averbis Partner to Integrate Text Mining Tools in Life Sciences Suite

Amplexor and Averbis Partner to Integrate Text Mining Tools in Life Sciences Suite

Full text analytics capability will complement existing platform and facilitate achieving IDMP compliance at a fraction of cost.

Amplexor is delighted to announce our official partnership with Averbis, to incorporate Averbis tools and services into the broader Amplexor Life Sciences solution suite. The alliance will help both companies target new markets worldwide.

 This partnership demonstrates that advanced AI-based technologies can enable customers by supporting specific IDMP relevant use cases, improving the quality and efficiency of regulatory operations, reducing costs and accelerating time to market while maintaining full compliance. In future, these technologies will extend to areas beyond IDMP, further underlining the value of the partnership. Read the full partnership announcement here.

Get in touch with an expert

Connect with us today!

Acolad Group and Amplexor – a new journey begins

Acolad Group and Amplexor – a new journey begins

Acolad Group and Amplexor – a new journey begins

As announced in September, Amplexor is now officially part of the Acolad Group. The merger will reinforce the group’s worldwide presence and its technological and commercial excellence for the future, strengthening their worldwide position as a leading Content and Language Service Provider.

Comprehensive, in-depth expertise across industries

As a group, Acolad and Amplexor pass the symbolic threshold of 2,000 employees and have a combined turnover of more than 270 million euros for the 2019 year.

With this merger milestone, decades of expertise in delivering professional language and content services for a range of highly specified industries are joining forces. Acolad’s broad presence and cross-selling capabilities are being completed with Amplexor’s comprehensive portfolio of content management and digital experience solutions and its leading position in the US, Eastern European and DACH markets.

The next goal: Top 3 Language Service Providers worldwide

Both parties are currently concentrating their efforts on achieving a successful integration. This will be key to pursue their common ambition: becoming one of the top 3 LSP worldwide leaders. Meanwhile, global operations remain unchanged to ensure 100% continuity for all customers. Within short term, the group’s portfolio of services will increase, becoming even more versatile for clients and business partners.

New governance stands for continuity and innovation

The Acolad Group board of directors now includes Olivier Marcheteau as CEO of the combined Group and Benjamin du Fraysseix, Guillaume Patry and Mark Evenepoel as Board Members and advisors.

“I am very excited today as this great project is becoming true. We are concentrating all our efforts on making this integration a success – currently setting up a process to design the shape of the combined organization, including both Acolad and Amplexor sponsors. We will build a bright future together, for our clients, partners and employees.”
Olivier Marcheteau, CEO of the Acolad Group.

Get in touch with an expert

Connect with us today!